(0.28%) 5 202.20 points
(0.45%) 39 233 points
(0.15%) 16 328 points
(0.41%) $79.31
(4.34%) $2.28
(0.68%) $2 338.10
(2.91%) $28.41
(0.80%) $992.50
(-0.20%) $0.928
(-0.19%) $10.87
(-0.11%) $0.799
(0.90%) $92.57
Quarter results today
(bmo 2024-05-09)
Expected move: +/- 0.00%
0.24% $ 2.09
Live Chart Being Loaded With Signals
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial...
Stats | |
---|---|
Dzisiejszy wolumen | 3 133.00 |
Średni wolumen | 90 147.00 |
Kapitalizacja rynkowa | 17.80M |
EPS | $0 ( 2024-05-03 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.140 |
ATR14 | $0.0350 (1.68%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-22 | Linscott Walt Addison | Buy | 75 000 | Stock Option (Right to Buy) |
2024-01-22 | Waltzman Roger J. | Buy | 75 000 | Stock Option (Right to Buy) |
2024-01-22 | Sassi Nir | Buy | 40 000 | Stock Option (Right to Buy) |
2024-01-22 | Meckler Jeffrey A | Buy | 100 000 | Stock Option (Right to Buy) |
2024-01-22 | Newman Michael James | Buy | 43 250 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 90 transactions |
Buy: 2 551 706 | Sell: 72 874 |
Indaptus Therapeutics, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Indaptus Therapeutics, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1 284.00 (0.00 %) |
EPS: | $-1.840 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1 284.00 (0.00 %) |
EPS: | $-1.840 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1 781.00 (0.00 %) |
EPS: | $-1.660 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.890 |
Financial Reports:
No articles found.
Indaptus Therapeutics,
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej